Importance of CD80/CD86-CD28 interactions in the recognition of target cells by CD8+CD122+ regulatory T cells

Immunology

Volumn 124, Issue 1, 2008, Pages 121-128

  Shi, Zhe ^a   Rifa'i, Muhaimin ^a   Lee, Young Ho ^a   Shiku, Hiroshi ^b   Isobe, Ken Ichi ^a   Suzuki, Haruhiko ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b BRAWIJAYA UNIVERSITY   (Indonesia)

Author keywords

CD28; CD80 86; MHC class I; Regulatory T cells (Treg)

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD3 ANTIBODY; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR BETA; NEUTRALIZING ANTIBODY; OKT 8;

ANIMAL CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL ISOLATION; CELL STIMULATION; CELL SURFACE; CYTOKINE PRODUCTION; EXPERIMENT; IN VITRO STUDY; KNOCKOUT MOUSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MECHANICS; MOLECULAR RECOGNITION; MOLECULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TARGET CELL;

ANIMALS; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD80; ANTIGENS, CD86; CELLS, CULTURED; IMMUNE TOLERANCE; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR BETA SUBUNIT; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 42149173305     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02747.x     Document Type: Article

References (26)

1. + regulatory T cells in the maintenance of T cell homeostasis. J Exp Med 2004 200: 1123 34.
2. Suzuki H, Kundig TM, Furlonger C et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 1995 268: 1472 6.
3. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998 10: 1969 80.
4. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998 188: 287 96.
5. + immunoregulatory T cells is antigen nonspecific. J Immunol 2000 164: 183 90.
6. + T cells. J Immunol 2005 175: 7093 7.
7. + cytolytic T cells. Nature 1990 344: 742 6.
8. Perrin PJ, June CH, Maldonado JH, Ratts RB, Racke MK. Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis. J Immunol 1999 163: 1704 10.
9. + cytotoxic T lymphocytes in the absence of exogenous help. J Exp Med 1993 177: 1791 6.
10. Shahinian A, Pfeffer K, Lee KP et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993 261: 609 12.
11. Borriello F, Sethna MP, Boyd SD et al. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 1997 6: 303 13.
12. von Boehmer H. Mechanism of suppression by suppressor T cells. Nat Immunol 2005 6: 338 44.
13. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000 12: 431 40.
14. Yu XZ, Martin PJ, Anasetti C. Role of CD28 in acute graft-versus-host disease. Blood 1998 92: 2963 70.
15. + T cells restricted by the MHC class Ib molecule, Qa-1. Annu Rev Immunol 2000 18: 185 210.
16. Berke G, McVey E, Hu V, Clark WR. T lymphocyte-mediated cytolysis. II. Role of target cell histocompatibility antigens in recognition and lysis. J Immunol 1981 127: 782 7.
17. + regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001 2: 301 6.
18. Tai X, Cowan M, Feigenbaum L et al. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 2005 6: 152 62.
19. - T cells. Int Immunol 1998 10: 775 83.
20. + regulatory T cell function. Eur J Immunol 2004 34: 2996 3005.
21. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000 192: 303 10.
22. Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, Thompson CB, Bluestone JA. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994 1: 405 13.
23. Waterhouse P, Penninger JM, Timms E et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995 270: 985 8.
24. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995 3: 541 7.
25. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med 2004 199: 1479 89.
26. + T cell tolerance through PD-1 and CTLA-4. Nat Immunol 2005 6: 280 6.